RecruitingNCT03865420

Amyotrophic Lateral Sclerosis (ALS) Families Project


Sponsor

Columbia University

Enrollment

300 participants

Start Date

Sep 11, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

This program provides family members of individuals with familial ALS the opportunity to contribute to research focused on learning more about why motor neuron degeneration begins and how or why it progresses. This study provides genetic counseling and testing to help participants understand and manage their risk and determine if they want to learn their genetic status. This study will follow unaffected ALS gene mutation carriers on an annual basis to gather essential information that will ultimately help researchers develop novel therapies for the prevention and treatment of ALS.


Eligibility

Min Age: 18 YearsMax Age: 105 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with als. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 105 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Columbia University

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03865420


Related Trials